Abstract:Objective To compare the effect of different short-term intensive treatments with insulin or metformin and glargine or metformin and glimepiride on metabolic control,B-cell function and insulin sensitivity in newly diagnosed type 2 diabetic patients.Methods From March 2005 to April 2006,48 newly diagnosed type 2 diabetic patients with fasting plasma glucose(FBG)of 7.0～11.0 mmol/L were randomly divided into three groups.The patients were treated with insulin or glargine and metformin or glimepiride and metformin for 3 months,respectively.FBG,postprandial blood glucose(PBG)、haemoglobin A1c(HbA1c)and lipid profiles were measured,and oral glucose tolerance test(OGTT)was performed before and after the treatment.Fifteen patients received intravenous glucose tolerance test(IVGTT).Results There showed excellent control of blood-glucose;blood-fat and B-cell function were improved significantly.Patients treated with insulin alone had greatest decrease in terms of HbA1c when compared with the other two groups.Conclusion Excellent metabolic control and B-cell function and insulin sensitivity improvement can be achieved with three short-term intensive anti-glycemic strategies,esp.with insulin treatment regimen.

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.